Last reviewed · How we verify

NCT03587402

Effects of Transcutaneous Perineal Stimulation Versus Anal Stimulation

Completed NA Last updated 8 October 2020
What this trial tests

NA trial testing Transcutaneous perineal stimulation in Urinary Incontinence in 70 participants. Completed in 6 October 2020.

Timeline
1 February 2019
Primary endpoint
30 July 2019
6 October 2020

Quick facts

Lead sponsorRAPbarcelona
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment70
Start date1 February 2019
Primary completion30 July 2019
Estimated completion6 October 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

RAPbarcelona

Who can join

18 and older, male only, with Urinary Incontinence or Radical Prostatectomy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates whether surface perineal stimulation is as effective as anal stimulation in reducing urinary incontinence secondary to radical prostatectomy. Half of participants will receive a treatment with surface perineal stimulation, while the other half will receive a treatment with anal stimulation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy of transcutaneous perineal electrostimulation versus intracavitary anal electrostimulation in the treatment of urinary incontinence after a radical prostatectomy: randomized controlled trial study protocol.
    Pané-Alemany R, Ramírez-García I, Carralero-Martínez A, Blanco-Ratto L, et al · · 2021 · cited 6× · PMID 33509164 · DOI 10.1186/s12894-020-00718-y

Verify or expand the search:

Other recruiting trials for Urinary Incontinence

Currently open trials in the same condition.

Other RAPbarcelona trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03587402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing